Recent Updates
Recently added Catalysts
TNGX Positive Sentiment Score: 70/100

Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Tuesday, February 3, 2026 1 min read
Key Takeaway: Tango Therapeutics will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026, with CEO Malte Peters scheduled for a fireside chat. The event is set for February 12, 2026, and will be available via a live webcast. The company focuses on precision medicine and synthetic lethality in cancer treatment.

Market Sentiment Analysis

POSITIVE FACTORS

  • Tango Therapeutics is actively participating in a prominent biotech summit.
  • The event provides a platform for discussing innovative cancer treatments.
  • The webcast allows broader access to the company's insights and developments.

Full Press Release Details

BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026 at 2:00 PM EST.
The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.

Investors and Media:

Elizabeth HickinIR@tangotx.commedia@tangotx.com

Frequently Asked Questions

When is the Guggenheim Biotech Summit 2026?

The summit is scheduled for February 12, 2026.

Who will represent Tango Therapeutics at the summit?

Malte Peters, M.D., the CEO of Tango Therapeutics, will participate.

How can I watch the summit presentation?

The live webcast will be available on the company's Investors page.

What is the focus of Tango Therapeutics?

Tango Therapeutics focuses on precision medicine and synthetic lethality for cancer.

Tags: TNGX Viatris Investor Conferences Healthcare Tango Therapeutics biotech summit precision medicine cancer treatment
Last updated: Feb 3, 2026